Akso Health Group ADR
$ 1.40
2.19%
24 Feb - close price
- Market Cap 807,325,000 USD
- Current Price $ 1.40
- High / Low $ 1.40 / 1.25
- Stock P/E N/A
- Book Value 0.36
- EPS -0.48
- Next Earning Report -
- Dividend Per Share N/A
- Dividend Yield 0 %
- Next Dividend Date -
- ROA -0.01 %
- ROE -0.80 %
- 52 Week High 2.10
- 52 Week Low 0.83
About
Akso Health Group ADR is a prominent player in the healthcare sector, dedicated to providing innovative medical solutions and integrated patient care services. The company specializes in advanced health technologies and is strategically positioned to leverage growth opportunities in telehealth and personalized medicine through its strong emphasis on research and development. With a robust business model and a commitment to quality, Akso Health Group's dedicated team of professionals enhances its attractiveness to institutional investors seeking to capitalize on the evolving dynamics of the healthcare landscape.
Analyst Target Price
N/A
Quarterly Earnings
| Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Jun 2024 | Mar 2024 | Dec 2023 | Sep 2023 | Jun 2023 | Mar 2023 | Dec 2022 | Sep 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported Date | 2025-11-04 | 2025-08-14 | 2025-06-17 | 2025-02-28 | 2024-09-18 | 2024-06-18 | 2024-01-11 | 2023-12-18 | 2023-09-20 | 2023-06-20 | 2023-03-02 | 2022-12-19 |
| Reported EPS | 0 | -0.4 | -0.4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Estimated EPS | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Surprise | 0 | -0.4 | -0.4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Surprise Percentage | None% | None% | None% | None% | None% | None% | None% | None% | None% | None% | None% | None% |
Next Quarterly Earnings
| Reported Date |
| Fiscal Date Ending |
| Estimated EPS |
| Currency |
Previous Dividend Records
| Jan 1970 | |
|---|---|
| Payment Date | None |
| Amount | $0.4 |
Next Dividend Records
| Dividend per share (year): | - |
| Dividend Yield | - |
| Next Dividend Date | - |
| Ex-Dividend Date | - |
Recent News: AHG
2026-02-10 09:27:43
Strategy reported strong Q4 results, surpassing revenue expectations with $122.99 million and adjusted earnings of $16.37 per share. Despite thisbeat, the company's stock dipped 4.8% in pre-market trading, reflecting broader market concerns as U.S. stock futures, including the Nasdaq 100, were lower. This suggests a cautious market sentiment potentially impacting tech stocks and overall investment strategies despite positive individual company performance.
2026-02-09 13:28:32
U.S. stock futures were down on Monday, with the Nasdaq 100 futures falling around 100 points. Several companies, including Strategy Inc, Hims & Hers Health Inc, Akso Health Group, and Bitmine Immersion Technologies Inc, saw their shares decline in pre-market trading, largely influenced by a drop in Bitcoin prices or other company-specific news. Despite a strong fourth-quarter earnings report that beat analyst estimates, Strategy Inc's shares still dipped.
2026-02-06 19:24:05
Akso Health Group has announced a strategic shift towards the healthcare industry, focusing on oncology with a new global program aimed at cancer care. The initiative seeks to integrate traditional Chinese medicine with advanced oncology to support patients. This move represents a significant transformation for the company, which has restructured its business model to center entirely on medical services and devices, moving away from its previous credit and e-commerce ventures.
2026-02-03 14:28:36
Akso Health Group announced an exploratory global patient support initiative and a strategic cooperation with Nanning Duoling Research Institute to provide free in-hospital treatment plans for up to 10,000 eligible cancer patients. The program integrates Traditional Chinese Medicine practice with modern medical technology, connecting radiation oncology centers, targeted drugs, and remote consultation teams. While aiming to address high medical costs and accessibility, the initiative is exploratory, conditional, and services will be delivered by independent medical institutions, not directly by Akso Health.
2026-02-03 08:29:08
Short interest in Akso Health Group Sponsored ADR (NASDAQ:AHG) decreased by 15.3% in January, totaling 14,650 shares. This leaves a days-to-cover ratio of 0.5 days, with only 0.0% of the shares currently sold short. Despite a recent 1.8% rise, the stock trades below its 50-day and 200-day simple moving averages, and analysts, including Weiss Ratings, maintain a consensus "Sell" rating.
2026-01-30 11:35:00
Akso Health Group (AHG) has shown a remarkable 415.8% revenue growth in the healthcare sector, primarily through its Xiaobai Maimai App in China. Despite this surge, the company faces significant profitability challenges, evidenced by a negative EPS and ROI, and lacks analyst coverage, leading to investor uncertainty. Its stock exhibits volatility, and while free cash flow is strong, the absence of dividends and neutral technical indicators suggest a cautious approach for potential investors until profitability improves.
